Global Anticoagulants Market Research Report 2022

1 Anticoagulants Market Overview 1

1.1 Product Overview and Scope of Anticoagulants 1

1.2 Anticoagulants Segment by Types 2

1.2.1 Global Production Market Share of Anticoagulants by Types in 2016 2

1.2.2 Platelet aggregation inhibitors (PAI) 3

1.2.3 Low-molecular-weight Heparin (LMWH) 4

1.2.4 Direct thrombin inhibitor (DTI) 4

1.2.5 Direct factor Xa inhibitors (DFXa) 5

1.2.6 Vitamin K antagonists (VKA) 5

1.3 Anticoagulants Segment by Applications 6

1.3.1 Anticoagulants Consumption Market Share by Applications in 2016 6

1.3.2 VTE 7

1.3.3 ACSMI 8

1.3.4 AF 9

1.4 Anticoagulants Market by Regions 10

1.4.1 North America Status and Prospect (2012-2022) 10

1.4.2 Europe Status and Prospect (2012-2022) 11

1.4.3 Japan Status and Prospect (2012-2022) 11

1.4.4 Asia (Ex.Japan) Status and Prospect (2012-2022) 12

1.5 Global Market Size (Value) of Anticoagulants (2012-2022) 13

2 Global Anticoagulants Market Competition by Manufacturers 14

2.1 Global Anticoagulants Revenue and Share by Manufacturers (2015 and 2016) 14

2.2 Global Anticoagulants Gross Margin by Manufacturers (2015 and 2016) 16

2.3 Manufacturers Anticoagulants Headquarters, Sales Area, Brand 17

2.4 Anticoagulants Market Competitive Situation and Trends 19

2.4.1 Anticoagulants Market Concentration Rate 19

2.4.2 Anticoagulants Market Share of Top 3 and Top 5 Manufacturers 20

2.4.3 Mergers & Acquisitions, Expansion 21

3 Global Anticoagulants Revenue (Value) by Regions (2012-2017) 24

3.1 Global Anticoagulants Revenue (Value) and Market Share by Regions (2012-2017) 24

3.2 Global Anticoagulants Revenue and Gross Margin (2012-2017) 27

3.3 North America Anticoagulants Revenue and Gross Margin (2012-2017) 27

3.4 Europe Anticoagulants Revenue and Gross Margin (2012-2017) 27

3.5 Japan Anticoagulants Revenue and Gross Margin (2012-2017) 28

3.6 Asia (Ex.Japan) Anticoagulants Revenue and Gross Margin (2012-2017) 28

4 Global Anticoagulants Supply, Consumption, Export, Import by Regions (2012-2017) 29

4.1 Global Anticoagulants Consumption by Regions (2012-2017) 29

4.2 North America Anticoagulants Production, Consumption, Export, Import by Regions (2012-2017) 32

4.3 Europe Anticoagulants Production, Consumption, Export, Import by Regions (2012-2017) 32

4.4 Japan Anticoagulants Production, Consumption, Export, Import by Regions (2012-2017) 32

4.5 Asia (Ex.Japan) Anticoagulants Production, Consumption, Export, Import by Regions (2012-2017) 33

5 Global Anticoagulants Revenue by Types 34

5.1 Global Anticoagulants Revenue and Market Share by Types (2012-2017) 34

5.2 Global Anticoagulants Revenue Growth by Type (2012-2017) 37

6 Global Anticoagulants Market Analysis by Application 38

6.1 Global Anticoagulants Consumption and Market Share by Application (2012-2017) 38

6.2 Global Anticoagulants Consumption Growth Rate by Application (2012-2017) 41

6.3 Market Drivers and Opportunities 41

6.3.1 Potential Applications 41

6.3.2 Market Drivers 42

7 Analysis of Anticoagulants Industry Key Manufacturers 43

7.1 Sanofi 43

7.1.1 Company Profile 43

7.1.2 Product Information 44

7.1.3 Revenue, Cost, Gross, and Gross Margin 45

7.2 Bayer 46

7.2.1 Company Profile 46

7.2.2 Product Information 47

7.2.3 Revenue, Cost, Gross, and Gross Margin 47

7.3 Boehringer Ingelheim 48

7.3.1 Company Profile 48

7.3.2 Product Information 49

7.3.3 Revenue, Cost, Gross, and Gross Margin 50

7.4 Johnson & Johnson 50

7.4.1 Company Profile 50

7.4.2 Product Information 51

7.4.3 Revenue, Cost, Gross, and Gross Margin 52

7.5 Genentech (Roche) 52

7.5.1 Company Profile 52

7.5.2 Product Information 53

7.5.3 Revenue, Cost, Gross, and Gross Margin 54

7.6 AstraZeneca 55

7.6.1 Company Profile 55

7.6.2 Product Information 56

7.6.3 Revenue, Cost, Gross, and Gross Margin 56

7.7 Bristol-Myers Squibb 57

7.7.1 Company Profile 57

7.7.2 Product Information 57

7.7.3 Revenue, Cost, Gross, and Gross Margin 58

7.8 Aspen 59

7.8.1 Company Profile 59

7.8.2 Product Information 60

7.8.3 Revenue, Cost, Gross, and Gross Margin 61

7.9 Lilly 62

7.9.1 Company Profile 62

7.9.2 Product Information 63

7.9.3 Revenue, Cost, Gross, and Gross Margin 63

7.10 Otsuka 64

7.10.1 Company Profile 64

7.10.2 Product Information 65

7.10.3 Revenue, Cost, Gross, and Gross Margin 66

7.11 Pfizer 66

7.11.1 Company Profile 66

7.11.2 Product Information 67

7.11.3 Revenue, Cost, Gross, and Gross Margin 68

7.12 Daiichi Sankyo 68

7.12.1 Company Profile 68

7.12.2 Product Information 69

7.12.3 Revenue, Cost, Gross, and Gross Margin 70

7.13 The Medicines Company 70

7.13.1 Company Profile 70

7.13.2 Product Information 71

7.13.3 Revenue, Cost, Gross, and Gross Margin 72

8 Anticoagulants Manufacturing Cost Analysis 73

8.1 Anticoagulants R&D Cost Analysis 73

8.1.1Clinical Phase Costs 74

8.1.2 Capitalized Costs 75

8.2 Proportion of Manufacturing Cost Structure 76

8.2.1 Raw Materials 76

8.2.2 Labor Cost 77

8.2.3 Manufacturing Expenses 83

8.3 Manufacturing Process Analysis of Anticoagulants 84

9 Industrial Chain, Sourcing Strategy and Downstream Buyers 85

9.1 Anticoagulants Industrial Chain Analysis 85

9.2 Upstream Raw Materials Sourcing 86

9.3 Downstream Buyers 86

10 Marketing Strategy Analysis, DistributorsTraders 88

10.1 Marketing Channel 88

10.2 Market Positioning 89

10.2.2 Brand Strategy 90

10.2.2.1 Introducing pharmaceutical branding strategies 90

10.2.2.2 Building pharmaceutical brands 91

10.2.2.3 Communicating pharmaceutical brands 92

10.2.2.4 Alternative brand models 92

10.2.2.5 The future of pharmaceutical branding 93

10.3 DistributorsTraders List 94

11 Market Effect Factors Analysis 95

11.1 Technology ProgressRisk 95

11.1.1 Substitutes Threat 95

11.1.2 Technology Progress in Related Industry 95

11.2 Consumer NeedsCustomer Preference Change 96

11.3 EconomicPolitical Environmental Change 96

12 Global Anticoagulants Market Forecast (2017-2022) 97

12.1 Global Anticoagulants Revenue Forecast (2017-2022) 97

12.2 Global Anticoagulants Revenue, Consumption Forecast by Regions (2017-2022) 97

12.3 Global Anticoagulants Revenue Forecast by Type (2017-2022) 98

12.4 Global Anticoagulants Consumption Forecast by Application (2017-2022) 98

13 Research Findings and Conclusion 100

14 Appendix 101

Author List 101

Disclosure Section 101

Research Methodology 102

Data Source 103

Disclaimer 103

Figure Picture of Anticoagulants 1

Figure Global Production Market Share of Anticoagulants by Types in 2016 2

Table Classification of Anticoagulants 2

Figure Product Picture of Platelet aggregation inhibitors (PAI) 3

Figure Product Picture of Low-molecular-weight Heparin (LMWH) 4

Figure Product Picture of Direct thrombin inhibitor (DTI) 4

Figure Product Picture of Direct factor Xa inhibitors (DFXa) 5

Figure Product Picture of Vitamin K antagonists (VKA) 5

Figure Anticoagulants Consumption Market Share by Applications in 2016 6

Table Applications of Anticoagulants 6

Figure VTE Examples 7

Figure ACS Examples 8

Figure MI Examples 9

Figure AF Examples 9

Figure North America Anticoagulants Revenue (M USD) and Growth Rate (2012-2022) 10

Figure Europe Anticoagulants Revenue (M USD) and Growth Rate (2012-2022) 11

Figure Japan Anticoagulants Revenue (M USD) and Growth Rate (2012-2022) 11

Figure Asia (Ex.Japan) Anticoagulants Revenue (M USD) and Growth Rate (2012-2022) 12

Figure Global Anticoagulants Revenue (M USD) and Growth Rate (2012-2022) 13

Table Global Anticoagulants Revenue (M USD) by Manufacturers (2015 and 2016) 14

Table Global Anticoagulants Revenue Share by Manufacturers (2015 and 2016) 14

Table 2015 Global Anticoagulants Revenue Share by Manufacturers 15

Table 2016 Global Anticoagulants Revenue Share by Manufacturers 16

Table Global Market Anticoagulants Gross Margin of Key Manufacturers (2015 and 2016) 16

Figure Global Market Anticoagulants Gross Margin of Key Manufacturers in 2016 17

Table Manufacturers Anticoagulants Headquarters and Sales Area 17

Table Anticoagulants Manufacturers Anticoagulants Major Brand 18

Figure Anticoagulants Market Revenue Concentration Rate in 2016 19

Figure Anticoagulants Revenue Market Share of Top 3 Manufacturers 20

Figure Anticoagulants Revenue Market Share of Top 5 Manufacturers 20

Table Mergers & Acquisitions, Expansion 21

Table Mergers & Acquisitions, Expansion 22

Table Mergers & Acquisitions, Expansion 23

Table Global Anticoagulants Revenue (M USD) by Regions (2012-2017) 24

Table Global Anticoagulants Revenue Market Share by Regions (2012-2017) 24

Figure Global Anticoagulants Revenue (M USD) by Regions (2012-2017) 25

Figure Global Anticoagulants Revenue Market Share by Regions (2012-2017) 25

Figure 2015 Global Anticoagulants Revenue Market Share by Regions 26

Figure 2016 Global Anticoagulants Revenue Market Share by Regions 26

Table Global Anticoagulants Revenue and Gross Margin (2012-2017) 27

Table North America Anticoagulants Revenue and Gross Margin (2012-2017) 27

Table Europe Anticoagulants Revenue and Gross Margin (2012-2017) 27

Table Japan Anticoagulants Revenue and Gross Margin (2012-2017) 28

Table Asia (Ex.Japan) Anticoagulants Revenue and Gross Margin (2012-2017) 28

Table Global Anticoagulants Consumption (M USD) Market by Regions (2012-2017) 29

Table Global Anticoagulants Consumption Market Share by Regions (2012-2017) 29

Figure Global Anticoagulants Consumption (M USD) Market by Regions (2012-2017) 30

Figure Global Anticoagulants Consumption Market Share by Regions (2012-2017) 30

Figure 2015 Global Anticoagulants Consumption Market Share by Regions 31

Figure 2016 Global Anticoagulants Consumption Market Share by Regions 31

Table North America Anticoagulants Production, Consumption, Import & Export (2012-2017) 32

Table Europe Anticoagulants Production, Consumption, Import & Export (2012-2017) 32

Table Japan Anticoagulants Production, Consumption, Import & Export (2012-2017) 32

Table Asia (Ex.Japan) Anticoagulants Production, Consumption, Import & Export (2012-2017) 33

Table Global Anticoagulants Revenue (M USD) by Types (2012-2017) 34

Table Global Anticoagulants Revenue Share by Types (2012-2017) 34

Figure Revenue (M USD) of Anticoagulants by Types (2012-2017) 35

Figure Revenue Share of Anticoagulants by Types (2012-2017) 35

Figure 2015 Revenue Market Share of Anticoagulants by Types 36

Figure 2016 Revenue Market Share of Anticoagulants by Types 36

Figure Global Anticoagulants Revenue Growth by Type (2012-2017) 37

Table Global Anticoagulants Consumption (M USD) by Application (2012-2017) 38

Table Global Anticoagulants Consumption Market Share by Application (2012-2017) 38

Figure Global Anticoagulants Consumption (M USD) by Application (2012-2017) 39

Figure Global Anticoagulants Consumption Market Share by Application (2012-2017) 39

Figure Global Anticoagulants Consumption Market Share by Application in 2015 40

Figure Global Anticoagulants Consumption Market Share by Application in 2016 40

Table Global Anticoagulants Consumption Growth Rate by Application (2012-2017) 41

Figure Global Anticoagulants Consumption Growth Rate by Application (2012-2017) 41

Table Sanofi Company Profile 43

Table Anticoagulants Product Picture and Specifications of Sanofi 44

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sanofi 2015 and 2016 45

Table Bayer Company Profile 46

Table Anticoagulants Product Picture and Specifications of Bayer 47

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Bayer 2015 and 2016 47

Table Boehringer Ingelheim Company Profile 48

Table Anticoagulants Product Picture and Specifications of Boehringer Ingelheim 49

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2015 and 2016 50

Table Johnson & Johnson Company Profile 50

Table Anticoagulants Product Picture and Specifications of Johnson & Johnson 51

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Johnson & Johnson 2015 and 2016 52

Table Genentech (Roche) Company Profile 52

Table Anticoagulants Product Picture and Specifications of Genentech (Roche) 53

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Genentech (Roche) 2015 and 2016 54

Table AstraZeneca Company Profile 55

Table Anticoagulants Product Picture and Specifications of AstraZeneca 56

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of AstraZeneca 2015 and 2016 56

Table Bristol-Myers Squibb Company Profile 57

Table Anticoagulants Product Picture and Specifications of Bristol-Myers Squibb 57

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2015 and 2016 58

Table Aspen Company Profile 59

Table Anticoagulants Product Picture and Specifications of Aspen 60

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Aspen 2015 and 2016 61

Table Lilly Company Profile 62

Table Anticoagulants Product Picture and Specifications of Lilly 63

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Lilly 2015 and 2016 63

Table Otsuka Company Profile 64

Table Anticoagulants Product Picture and Specifications of Otsuka 65

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Otsuka 2015 and 2016 66

Table Pfizer Company Profile 66

Table Anticoagulants Product Picture and Specifications of Pfizer 67

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Pfizer 2015 and 2016 68

Table Daiichi Sankyo Company Profile 68

Table Anticoagulants Product Picture and Specifications of Daiichi Sankyo 69

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2015 and 2016 70

Table The Medicines Company Company Profile 70

Table Anticoagulants Product Picture and Specifications of The Medicines Company 71

Table Anticoagulants Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of The Medicines Company 2015 and 2016 72

Figure typical phases from research to the market for a drug candidate 74

Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 75

Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 76

Figure Manufacturing Cost Structure of Anticoagulants 76

Figure Assessment of API Manufacturing Cost By Region 77

Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 78

Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016 79

Figure 2016 Global Manufacturing Competitiveness Index rankings by country 80

Figure US Nonfarm Unit Labor Cost 2014-2016 81

Figure United States Average Hourly Wages (USDH) 2016-2017 81

Figure China Labor Cost Index 2014-2016 82

Figure China Average Yearly Wages 2006-2016 82

Figure Euro Area Labor Cost 2014-2016 83

Figure Manufacturing Process Analysis of Anticoagulants 84

Figure Anticoagulants Industrial Chain Analysis 85

Table Major Buyers of Anticoagulants 86

Figure Marketing Channel for Anticoagulants 88

Figure Anticoagulants Marketing Channel 89

Table DistributorsTraders List 94

Figure Anticoagulants Development 95

Figure Global Anticoagulants Revenue (M USD) and Growth Rate Forecast (2017-2022) 97

Table Global Anticoagulants Revenue (M USD) Forecast by Regions (2017-2022) 97

Table Global Anticoagulants Consumption (M USD) Forecast by Regions (2017-2022) 98

Table Global Anticoagulants Revenue (M USD) Forecast by Type (2017-2022) 98

Table Global Anticoagulants Consumption (M USD) Forecast by Application (2017-2022) 98